← FDA Drug Approvals (Drugs@FDA)

STEGLUJAN

NDA · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2017-12-19

Drug application

FDA Application #

NDA209805

Application type

New Drug Application

Brand name

STEGLUJAN

Generic name

ERTUGLIFLOZIN AND SITAGLIPTIN

Active ingredients

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSD SUB MERCK

Manufacturer

Merck Sharp & Dohme LLC

First approval

2017-12-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown